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intravenous (IV) thrombolytics, for the treatment of AIS.
METHODS PubMed, Cochrane CENTRAL, EMBASE, EBSCO, Web of
Science and CINAHL databases were searched from 1/01/1995-06/10/
2015. We selected English language RCTs, comparing EVT plus IV tPA
with IV tPA alone in eligible patients for treatment of AIS. Clinical
endpoints of interest were good functional outcomes as represented
by modiﬁed Rankin Scale (mRS) of 0-2, all-cause mortality, and
symptomatic intracerebral hemorrhage (sICH).
RESULTS Ten randomized trials were included in our meta-analysis,
which randomized 2,915 patients with large vessel, anterior circula-
tion stroke. EVT signiﬁcantly improved the rate of functional inde-
pendence (90-day mRS of 0 to 2) when compared to IV thrombolytics
[Odds ratio (OR) 1.65, 95% CI 1.21-2.26]. There was a non-signiﬁcant
trend of lower mortality with EVT (OR 0.84, 95% CI 0.69-1.03). The
rate of sICH was not higher with EVT (OR 1.06, 95% CI 0.74-1.52).
CONCLUSIONS In recent trials with modern imaging and thrombec-
tomy devices in patients with AIS, EVT signiﬁcantly improved func-
tional outcomes and was as safe as conventional intravenous
thrombolytic therapy.
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Smartphone Based Applications Accurately Predict Rhythm Disturbances
and Diagnose Silent Atrial Fibrillation
Onkar Sandhu,1 Bipin Joshi1
1University of San Francisco at Fresno, Clovis, CA
BACKGROUND Use of smartphone-based applications for identifying
rhythm disturbances has been suggested. However their practical use
and appropriate utilization to screen for rhythm disorders in outpa-
tient settings remains undeﬁned.
METHODS I evaluated 103 consecutive patients in outpatient cardi-
ology clinics to identify underlying heart rhythm using smartphone-
based electrocardiogram (ECG) application, subsequently validated by
12-lead ECG. Two cardiologists blinded to the rhythm diagnosis
independently read both ECG tracings.
RESULTS Mean age was 6215 years, 49 (47.6%) patients were males
and 89% patients were Caucasians. Identiﬁcation of underlying heart
rhythm by smartphone-based application is shown in Figure 1-A,
which accurately identiﬁed sinus rhythm from Atrial Fibrillation
(AF) with sensitivity of 88%, speciﬁcity of 91% and positive
predictive value of 98%. Comparison of rhythm by smartphone
based application and 12-lead ECG showed an Intraclass correlation
coefﬁcient of 0.838 (95% Conﬁdence Interval: 0.7860-
0.890;p<0.001). Receiver operating characteristic curve for
smartphone-based application to diagnose AF showed area under
curve of 0.881.Superiority of Alivecor For Identifying Sinus Rhythm and Atrial FibrillationRhythm Analysis
by AlivecorAtrial Fibrillation
(n[8)Sinus rhythm
(n[92)Sensitivity 0.62 0.88Speciﬁcity 0.98 0.91Positive Predictive Value 0.83 0.98Negative Predictive Value 0.96 0.47Positive Likely hood ratios 59.37 9.68Negative Likely hood ratios 0.37 0.13CONCLUSIONS Smartphone-based ECG applications can accurately
determine rhythm disturbances and diagnose silent AF in outpatient
settings. In an era of evolving smartphones, such ECG applications may
be of value in risk assessment, guiding therapy and preventing strokes.
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BACKGROUND Clopidogrel plays a central role in the treatment of
patients undergoing carotid artery stenting (CAS). The inhibitory
response to clopidogrel considerably varies among individuals and
clopidogrel resistance is a risk factor for thrombotic events. Based on
the platelet aggregation evaluated by the VASP analysis, the present
study compared the outcome after carotid stenting guided with
optimal clopidogrel dose adjustment versus a groups treated with
double dose of clopidogrel without platelet monitoring.
METHODS From January 2002 until January 2014, 176 consecutive
patients underwent an elective carotid stenting. The ﬁrst group was
treated with clopidogrel, guided with VASP analysis and was compared
with a control groups treated with double dose of clopidogrel without
platelet monitoring. VASP phosphorylation was determined with
Platelet VASP kits according to the manufacturer’s instructions (Diag-
nostica Stago, Asnières, France). A ﬁrst VASP-phosphorylation analysis
was checked and considered safe if the platelet reactivity indexwas less
than 55%. If not, additional 75 mg loading dose was control checked by
another VASP-phosphorylation analysis.
RESULTS The study enrolled 176 patients. Of these, 130 patients were
treated with clopidogrel guided with VASP analysis (group 1), and 46
treated with double dose of clopidogrel without platelet monitoring
(group 2). At baseline, the clinical features and the procedural tech-
nique did not differ between the 2 groups. No additional gain of
mortality, ischemic event, cumulative incidence of target lesions
revascularization (TLR) or bleeding was obtained at 30 days, one-year
and Three –years in Group 1 versus Group 2. VASP monitoring was not
correlated to the occurrence of complications at one month and one-
year follow up (OR (95% CI): 1.06 (0.27 - 4.19) p:0,93) ; OR (95% CI):
1.07(1.39 - 2.92) p: 0,9; respectively) .
CONCLUSIONS Patients undergoing CAS treated with double-dose clo-
pidogrel have the same outcomes compared with a population treated
with clopidogrel guided with VASP analysis. VASP monitoring is not
associated with a lower incidence of death, ischemic event, cumulative
incidence of TLR or bleeding after CAS. Vu : 15:31 Appareil photo
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